Safety and efficacy of changing to the travoprost/timolol maleate fixed combination (DuoTrav) from prior mono- or adjunctive therapy

QR Code

Safety and efficacy of changing to the travoprost/timolol maleate fixed combination (DuoTrav) from prior mono- or adjunctive therapy

Norbert Pfeiffer1, Maria-Luise Scherzer2, Hubert Maier3, Sonja Schoelzel4, Mark C Jasek5, Jeanette A Stewart6, William C Stewart6 On behalf of the DuoTravMED study group1Johannes Gutenberg-Universit&auml;t Mainz, Mainz, Germany; 2Regenstauf, Germany; 3Gerolzhofen, Germany; 4Institutes of Mol...

Full description

Saved in:

Bibliographic Details
Main Authors:	Norbert Pfeiffer, Maria-Luise Scherzer, Hubert Maier, et al
Format:	article
Language:	EN
Published:	Dove Medical Press 2010
Subjects:	Ophthalmology RE1-994
Online Access:	https://doaj.org/article/5f3342e3d4c646aeae3e9f5eab6063f8
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Efficacy of the travoprost/timolol fixed combination versus the concomitant use of travoprost 0.004% and timolol 0.1% gel formulation
by: Kozobolis V, et al.
Published: (2018)

Efficacy and safety of fixed-combination travoprost 0.004%/timolol 0.5% in patients transitioning from bimatoprost 0.03%/timolol 0.5% combination therapy
by: Schnober D, et al.
Published: (2015)

Fixed combination of travoprost and timolol maleate reduces intraocular pressure in Japanese patients with primary open-angle glaucoma or ocular hypertension: analysis by prostaglandin analogue
by: Nakano T, et al.
Published: (2016)

The impact of timolol maleate on the ocular tolerability of fixed-combination glaucoma therapies
by: Radcliffe NM
Published: (2014)

Randomized trial comparing three fixed combinations of prostaglandins/prostamide with timolol maleate
by: Jaime Pablo Kelly Rigollet, et al.
Published: (2011)

Ocular hypotensive effect and safety of travoprost 0.004%/timolol maleate 0.5% fixed combination after change of treatment regimen from &szlig;-blockers and prostaglandin analogs
by: Inoue K, et al.
Published: (2012)

Safety and efficacy of fixed-combination travoprost/timolol in patients with open-angle glaucoma or ocular hypertension not controlled with timolol monotherapy
by: Jordão MLS, et al.
Published: (2014)

Safety and efficacy of switching from dorzolamide 1.0%/timolol maleate 0.5% eye drops to brinzolamide 1.0%/timolol maleate 0.5% eye drops
by: Inoue K, et al.
Published: (2015)

Efficacy and safety of travoprost/timolol vs dorzolamide/timolol in patients with open-angle glaucoma or ocular hypertension
by: Miguel A Teus, et al.
Published: (2009)

Maximum Medical Therapy: Brinzolamide/Brimonidine And Travoprost/Timolol Fixed-Dose Combinations In Glaucoma And Ocular Hypertension
by: Lerner SF, et al.
Published: (2019)

Twelve-week, randomized, multicenter study comparing a fixed combination of brimonidine-timolol with timolol as therapy adjunctive to latanoprost
by: Fechtner RD, et al.
Published: (2011)

Treatment persistence and cost-effectiveness of latanoprost/latanoprost&ndash;timolol, bimatoprost/bimatoprost&ndash;timolol, and travoprost/travoprost&ndash;timolol in glaucoma: an analysis based on the United Kingdom general practitioner research database
by: Antoine Lafuma, et al.
Published: (2011)

Safety, tolerability, and efficacy of fixed combination therapy with dorzolamide hydrochloride 2% and timolol maleate 0.5% in glaucoma and ocular hypertension
by: Nicholas P Bell, et al.
Published: (2010)

Intraocular pressure reduction of fixed combination timolol maleate 0.5% and dorzolamide 2% (Cosopt) administered three times a day
by: Moisseiev E,&nbsp;Lazar M, et al.
Published: (2012)

Efficacy and safety of travoprost 0.004%/timolol 0.5% fixed combination as transition therapy in patients previously on prostaglandin analog monotherapy
by: Costa VP, et al.
Published: (2012)

Solo, dúo, trío
by: Menanteau,Álvaro
Published: (2004)

Efficacy and safety of switching to latanoprost 0.005%–timolol maleate 0.5% fixed-combination eyedrops from an unfixed combination for 36 months
by: Inoue K, et al.
Published: (2014)

Efficacy and safety of a switch to latanoprost 0.005% + timolol maleate 0.5% fixed combination eyedrops from latanoprost 0.005% monotherapy
by: Inoue K, et al.
Published: (2012)

Intraocular pressure reduction using a fixed combination of timolol maleate 0.5% and brimonidine tartrate 0.2% administered three times daily
by: Moisseiev E, et al.
Published: (2013)

Assessment of ocular hypotensive effect and safety 12 months after changing from an unfixed combination to a latanoprost 0.005% + timolol maleate 0.5% fixed combination
by: Inoue K, et al.
Published: (2012)

Brinzolamide 1%/timolol versus dorzolamide 2%/timolol in the treatment of open-angle glaucoma or ocular hypertension: prospective randomized patient-preference study
by: Altafini R, et al.
Published: (2015)

Efficacy, safety, and improved tolerability of travoprost BAK-free ophthalmic solution compared with prior prostaglandin therapy
by: J Charles Henry, et al.
Published: (2008)

Efficacy Evaluation of 755-nm Long-Pulse Alexandrite Laser Combined with 0.5% Timolol Maleate Eye Drops in the Treatment of Thicker Infantile Hemangioma
by: Wu J, et al.
Published: (2021)

A study of the safety and efficacy of travoprost 0.004%/timolol 0.5% ophthalmic solution compared to latanoprost 0.005% and timolol 0.5% dosed concomitantly in patients with open-angle glaucoma or ocular hypertension
by: Douglas J Rhee, et al.
Published: (2008)

Stratification-Based Investigation of Adjunctive Brimonidine or Timolol to a Prostaglandin Analogue in Japanese Patients with Normal-Tension Glaucoma
by: Yoshikawa K, et al.
Published: (2021)

Deadly duo-aortic aneurysm with psoriasis - Case report
by: P. Shafi, et al.
Published: (2021)

Efficacy, safety, and tolerability of travoprost 0.004% BAK-free versus prior treatment with latanoprost 0.005% in Japanese patients
by: Michael J Miyashiro, et al.
Published: (2010)

Addition of a fixed combination of brinzolamide 1%/timolol 0.5% to prostaglandin monotherapy in patients with glaucoma or ocular hypertension
by: Lorenz K, et al.
Published: (2011)

Efficacy and safety of brinzolamide/timolol fixed combination compared with timolol in Japanese patients with open-angle glaucoma or ocular hypertension
by: Yoshikawa K, et al.
Published: (2014)

Effects of brinzolamide vs timolol as an adjunctive medication to latanoprost on circadian intraocular pressure control in primary open-angle glaucoma Japanese patients
by: Makoto Ishikawa, et al.
Published: (2009)

Switching from concomitant therapy to tafluprost/timolol fixed combination
by: Inoue K, et al.
Published: (2018)

Efficacy and safety of brinzolamide/timolol fixed combination compared with timolol in Japanese patients with open-angle glaucoma or ocular hypertension [Erratum]
by: Yoshikawa K, et al.
Published: (2014)

Preference for a fixed combination of brinzolamide/timolol versus dorzolamide/ timolol among patients with open-angle glaucoma or ocular hypertension
by: Sanseau A, et al.
Published: (2013)

The duo Clostridium and Lactobacillus linked to hydrogen production from a lignocellulosic substrate
by: Marisol Pérez-Rangel, et al.
Published: (2021)

Effect of preservative removal from fixed-combination bimatoprost/timolol on intraocular pressure lowering: a potential timolol dose–response phenomenon
by: Shen J, et al.
Published: (2016)

Engineering a synthetic pathway for maleate in Escherichia coli
by: Shuhei Noda, et al.
Published: (2017)

℗<U+00BF>Los derechos humanos a travÌes del desarrollo de competencias ciudadanas?
Published: (2009)

Transcription factor DUO1 generated by neo-functionalization is associated with evolution of sperm differentiation in plants
by: Asuka Higo, et al.
Published: (2018)

STRUCTURE AND THERMAL PROPERTIES OF MALEATED LIGNIN-RECYCLED POLYSTYRENE COMPOSITES
by: LISPERGUER,JUSTO, et al.
Published: (2013)

Human TRAV1-2-negative MR1-restricted T cells detect S. pyogenes and alternatives to MAIT riboflavin-based antigens
by: Erin W. Meermeier, et al.
Published: (2016)